CD
Carl Domino Portfolio holdings
AUM
$82M
This Quarter Return
+3.6%
1 Year Return
+19.36%
3 Year Return
+38.24%
5 Year Return
–
10 Year Return
–
AUM
$93.8M
AUM Growth
+$93.8M
(-11%)
Cap. Flow
-$15.1M
Cap. Flow
% of AUM
-16.14%
Top 10 Holdings %
Top 10 Hldgs %
21.23%
Holding
136
New
9
Increased
15
Reduced
62
Closed
18
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$1.26M |
| 2 |
Pitney Bowes
PBI
|
$867K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$421K |
| 4 |
PARA
Paramount Global Class B
PARA
|
$242K |
| 5 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$242K |
Top Sells
| 1 |
Home Depot
HD
|
$1.56M |
| 2 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
$1.37M |
| 3 |
Pfizer
PFE
|
$1.14M |
| 4 |
Gilead Sciences
GILD
|
$1.11M |
| 5 |
Johnson & Johnson
JNJ
|
$811K |
Sector Composition
| 1 | Technology | 21.19% |
| 2 | Financials | 14.17% |
| 3 | Industrials | 13.74% |
| 4 | Consumer Discretionary | 12.4% |
| 5 | Healthcare | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Opko Health
OPK
$1.1B
| $193K | 0.21% |
20,800
+4,000
| +24% | +$37.1K |
|
|
WLL
102
DELISTED
Whiting Petroleum Corporation
WLL
| $192K | 0.2% |
16,000
| – | – |
|
103
MBIA
MBI
$402M
| $182K | 0.19% |
17,000
-7,000
| -29% | -$74.9K |
|
104
Vivani Medical
VANI
$68.1M
| $174K | 0.19% |
88,411
+29,976
| +51% | +$59K |
|
|
GNMX
105
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $172K | 0.18% |
33,273
| – | – |
|
|
ENDP
106
DELISTED
Endo International plc
ENDP
| $165K | 0.18% |
+10,000
| New | +$165K |
|
107
Ocugen
OCGN
$319M
| $145K | 0.15% |
87,000
+52,989
| +156% | +$88.3K |
|
108
Lineage Cell Therapeutics
LCTX
$267M
| $119K | 0.13% |
33,000
+18,000
| +120% | +$64.9K |
|
109
Clear Channel Outdoor Holdings
CCO
$616M
| $112K | 0.12% |
22,085
| – | – |
|
110
Microvision
MVIS
$346M
| $108K | 0.12% |
86,000
-16,190
| -16% | -$20.3K |
|
|
AMRS
111
DELISTED
Amyris Inc.
AMRS
| $107K | 0.11% |
+147,000
| New | +$107K |
|
112
Geron
GERN
$893M
| $85K | 0.09% |
41,000
| – | – |
|
113
Vuzix
VUZI
$164M
| $82K | 0.09% |
+12,000
| New | +$82K |
|
|
ATRS
114
DELISTED
Antares Pharma, Inc.
ATRS
| $76K | 0.08% |
32,500
| – | – |
|
|
AVP
115
DELISTED
Avon Products, Inc.
AVP
| $76K | 0.08% |
15,000
+3,000
| +25% | +$15.2K |
|
116
VirnetX
VHC
$58.5M
| $57K | 0.06% |
26,000
-20,940
| -45% | -$45.9K |
|
117
Accuray
ARAY
$157M
| $55K | 0.06% |
11,862
-3,000
| -20% | -$13.9K |
|
118
Ekso Bionics
EKSO
$9.79M
| $52K | 0.06% |
+12,958
| New | +$52K |
|
119
APA Corp
APA
$8.31B
| – | – |
-5,056
| Closed | -$322K |
|
120
Bausch Health
BHC
$2.74B
| – | – |
-9,000
| Closed | -$225K |
|
121
CSX Corp
CSX
$60.6B
| – | – |
-8,450
| Closed | -$253K |
|
122
Chevron
CVX
$324B
| – | – |
-4,874
| Closed | -$494K |
|
123
Walt Disney
DIS
$213B
| – | – |
-4,369
| Closed | -$401K |
|
124
Garmin
GRMN
$46.5B
| – | – |
-6,175
| Closed | -$297K |
|
125
Halliburton
HAL
$19.4B
| – | – |
-8,121
| Closed | -$359K |
|